Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2012

Feb 29, 2012

30597_dirs_2012-02-29_2d8122bd-07dd-46bf-99b2-27c7ac9cadc9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2012-02-27

Reporting Person: ARORA MANEESH (Director, COO and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-27 Stock Option (right to buy) $9.07 A 52500 Acquired 2022-02-27 Common Stock (52500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 28814 Direct
Common Stock 7424 Indirect

Footnotes

F1: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.